Suberoylanilide hydroxamic acid induces limited changes in the transcriptome of primary CD4+ T cells-Reference-Cited by-同舟云学术

Suberoylanilide hydroxamic acid induces limited changes in the transcriptome of primary CD4+ T cells

Published:2013-01-02 Issue:1 Volume:27 Page:29-37
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Beliakova-Bethell Nadejda,Zhang Jin X.,Singhania Akul,Lee Vivian,Terry Valeri H.,Richman Douglas D.,Spina Celsa A.,Woelk Christopher H.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference44 articles.

1. Administration of HDAC inhibitors to reactivate HIV-1 expression in latent cellular reservoirs: implications for the development of therapeutic strategies.;Demonte;Biochem Pharmacol,2004

2. Histone deacetylase inhibitors for purging HIV-1 from latent reservoir.;Matalon;Mol Med,2011

3. Histonedeacetylase inhibitor Oxamflatin increase HIV-1 transcription by inducing histone modification in latently infected cells.;Yin;Mol Biol Rep,2011

4. Suberoylanilide Hydroxamic Acid Reactivates HIV from Latently Infected Cells.;Contreras;J Biol Chem,2009

5. Histone acetylase inhibitor Scriptaid reactivates latent HIV-1 promoter by inducing histone modification in in vitro latency cell lines.;Ying;Int J Mol Med,2010

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extensive proteomic and transcriptomic changes quench the TCR/CD3 activation signal of latently HIV-1 infected T cells;PLOS Pathogens;2021-01-19

2. Extensive proteomic and transcriptomic changes quench the TCR/CD3 activation signal of latently HIV-1 infected T cells;2020-06-30

3. Cellular Gene Modulation of HIV-Infected CD4 T Cells in Response to Serial Treatment with the Histone Deacetylase Inhibitor Vorinostat;Journal of Virology;2020-06-16

4. Assessing the impact of AGS-004, a dendritic cell-based immunotherapy, and vorinostat on persistent HIV-1 Infection;Scientific Reports;2020-03-20

5. Use of GapmeRs for gene expression knockdowns in human primary resting CD4+ T cells;Journal of Immunological Methods;2020-01